http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021188013-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f62c742b87bf1c93c55fed3f7db7ef4c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate | 2021-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75bc8da78ce7160dd9719ef280b5768d |
publicationDate | 2021-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2021188013-A1 |
titleOfInvention | Method for treating endometriosis and concomitant formation of adhesions |
abstract | The invention relates to the field of medicine and may be used in treatment and prophylaxis of female reproductive system diseases. A method for treating endometriosis and concomitant formation of adhesions consists in an oral administration of a drug comprising a complex of 3,3'-diindolylmethane with β-cyclodextrin at a dosage of 400-600 mg of 3,3'-diindolylmethane per day. Said ingredients are present in the following ratio, wt %: 3,3'-diindolylmethane 10-20, β-cyclodextrin 80-90. A tablet dosage form is preferred for administration of the drug. The use of the active substance 3,3'-diindolylmethane complexed with β-cyclodextrin makes it possible to increase the bioavailability of the active substance, hence to increase the treatment efficacy. |
priorityDate | 2020-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.